Related references
Note: Only part of the references are listed.A Very Short Course of HBIg plus NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients
Matteo A. Manini et al.
TRANSPLANTATION PROCEEDINGS (2021)
Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience
Jassin Rashidi-Alavijeh et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV-related diseases in the era of potent nucleos(t)ide analogues: A meta-analysis
Ming Shu Li et al.
JOURNAL OF DIGESTIVE DISEASES (2021)
Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta-analysis
Quirino Lai et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation
Christophe Duvoux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Entecavir Monotherapy Prevents Hepatitis B Virus Recurrence After Liver Transplant for Chronic Hepatitis B Patients: A Long-Term Retrospective Study
Ying Liu et al.
TRANSPLANTATION PROCEEDINGS (2021)
Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious
Mark D. Muthiah et al.
HEPATOLOGY INTERNATIONAL (2020)
Liver transplantation for Hepatitis-B-associated liver disease - Three decades of experience
Eva Maria Teegen et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety
Samar K. Darweesh et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation
Wei-Chen Lee et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal
Matteo A. Manini et al.
DIGESTIVE AND LIVER DISEASE (2018)
Long-Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years
James Fung et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
Kavita Radhakrishnan et al.
TRANSPLANTATION (2017)
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
Ramazan Idilman et al.
CLINICAL TRANSPLANTATION (2016)
Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis
Ji-Na Zheng et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
I. Fernandez et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
N. S. Choudhary et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Limited Hepatitis B Immunoglobulin With Potent Nucleos(t)ide Analogue Is a Cost-Effective Prophylaxis Against Hepatitis B Virus After Liver Transplantation
G. A. Singer et al.
TRANSPLANTATION PROCEEDINGS (2015)
Prophylaxis against hepatitis B virus recurrence after liver transplantation: A registry study
Shu Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The efficacy and safety of tenofovir in the prevention of Hepatitis B virus recurrence following liver transplantation
Gozde Dervis Hakim et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2014)
Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation
Gun Hyung Na et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
A clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients
Yin-jie Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Peijie Wang et al.
PLOS ONE (2014)
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
Living Donor Liver Transplantation: The Asian Perspective
Yu-Fan Cheng et al.
TRANSPLANTATION (2014)
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation
Tomohiro Tanaka et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Recovering the raw data behind a non-parametric survival curve
Zhihui Liu et al.
SYSTEMATIC REVIEWS (2014)
Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation
Yoshihide Ueda et al.
HEPATOLOGY RESEARCH (2013)
Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin
Nam-Joon Yi et al.
JOURNAL OF GASTROENTEROLOGY (2013)
HEPATITIS B PROPHYLAXIS POST LIVER TRANSPLANTATION WITH TENOFOVIR OR ENTECAVIR
H. Elsiesy et al.
JOURNAL OF HEPATOLOGY (2013)
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
Robert Perrillo et al.
LIVER TRANSPLANTATION (2013)
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
Lewis W. Teperman et al.
LIVER TRANSPLANTATION (2013)
Clinical Outcomes and Risk Factors of Hepatitis B Virus Recurrence in Patients Who Received Prophylaxis With Entecavir and Hepatitis B Immunoglobulin Following Liver Transplantation
Y-K. Kim et al.
TRANSPLANTATION PROCEEDINGS (2013)
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Clinical study on prevention of HBV re-infection by entecavir after liver transplantation
Chang-jie Cai et al.
CLINICAL TRANSPLANTATION (2012)
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation
R. Todd Stravitz et al.
LIVER INTERNATIONAL (2012)
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Posttransplantation Prophylaxis With Primary High-Dose Hepatitis B Immunoglobulin Monotherapy and Complementary Preemptive Antiviral Add-On
Shin Hwang et al.
LIVER TRANSPLANTATION (2011)
Hepatitis B Immunoglobulin and/or Nucleos(t)ide Analogues for Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
Evangelos Cholongitas et al.
LIVER TRANSPLANTATION (2011)
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
L. H. Katz et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
The role of entecavir in preventing hepatitis B recurrence after liver transplantation
Zhi Feng Xi et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J. Gane et al.
GASTROENTEROLOGY (2007)
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation
G Ferretti et al.
TRANSPLANTATION PROCEEDINGS (2004)
Share Paper
